NASDAQ: FHLTFuture Health Esg Corp Stock
$11.50+0.77 (+7.18%)
Updated Apr 22, 2024
FHLT Price
$11.50
Fair Value Price
$0.02
Market Cap
$68.27M
52 Week Low
$9.97
52 Week High
$15.05
P/E
-1,150x
P/B
-6.64x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$48.43k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.7
Operating Cash Flow
-$718k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FHLT Overview
Future Health ESG Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets the smart health technology sector. Future Health ESG was incorporated in 2021 and is based in Dover, DE.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FHLT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FHLT ($11.50) is overvalued by 63,168.94% relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FHLT ($11.50) is not significantly undervalued (63,168.94%) relative to our estimate of its Fair Value price of $0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FHLT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FHLT due diligence checks available for Premium users.
Be the first to know about important FHLT news, forecast changes, insider trades & much more!
FHLT News
Valuation
FHLT fair value
Fair Value of FHLT stock based on Discounted Cash Flow (DCF)
Price
$11.50
Fair Value
$0.02
Overvalued by
63,168.94%
FHLT ($11.50) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FHLT ($11.50) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FHLT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
FHLT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1,150x
Industry
35.31x
Market
41x
FHLT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-6.64x
Industry
-14.28x
FHLT's financial health
Profit margin
Revenue
$0.0
Net Income
-$58.4k
Profit Margin
0%
FHLT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$17.2M
Liabilities
$17.4M
Debt to equity
-1.7
FHLT's short-term liabilities ($8.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FHLT's long-term liabilities ($9.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FHLT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FHLT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$138.1k
Investing
$0.0
Financing
$0.0
FHLT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FHLT vs Shell Company Stocks
Future Health Esg Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.